Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-2,141
Closed -$399K – 229
2018
Q2
$399K Buy
+2,141
New +$356K 0.23% 65
2018
Q1
– Sell
-2,185
Closed -$264K – 219
2017
Q4
$264K Buy
+2,185
New +$241K 0.15% 42

Other funds holding INGN

Ibex Investors's INGN Position: Q3 2018 in Review

Ibex Investors sold out of Inogen (INGN) in Q3 2018, closing a stake of 2,141 shares — an estimated $399K sold.

Ibex Investors first reported a position in INGN in Q4 2017 and held it in 2 quarters. The position peaked at $399K in Q2 2018. 282 funds tracked by Wall St. Rank hold INGN as of Q3 2018.

  • Ibex Investors reported no remaining Inogen position as of Q3 2018 after selling out during the quarter.
  • Ibex Investors sold 2,141 Inogen shares in Q3 2018, an estimated $399K.
  • Ibex Investors first reported a position in Inogen in Q4 2017 and held it in 2 quarters.
  • Ibex Investors's Inogen position peaked at $399K in Q2 2018.
  • 282 funds tracked by Wall St. Rank held Inogen as of Q3 2018.

Based on Ibex Investors's 13F filing for Q3 2018, filed 13 Nov 2018.